Mirati drug combination shrinks tumours in 39 per cent of colon cancer patients in study
Adagrasib targets a mutated form of a gene known as KRAS that occurs in around 13 per cent of non-small cell lung cancers, three…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.